StockData

Delcath Systems vs InfuSystem

DCTH and INFU side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DCTH and INFU compare

Delcath Systems is the larger company, worth 2.4 times as much as InfuSystem ($713M against $293M).

On earnings, InfuSystem is cheaper: it trades at 32.7× trailing earnings, against 128× for Delcath Systems.

Delcath Systems grew revenue faster over the last twelve months (38.1% versus 2.4% for InfuSystem).

InfuSystem keeps more of each dollar of sales as profit, with a net margin of 6.5% compared with 6.1% at Delcath Systems.

InfuSystem scores higher on the StockData Score (15 against 14 for Delcath Systems), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDCTHINFU
Size and price
Market cap$713M$293M
Share price$20.55$14.72
Change, 1 year139%41.1%
Change, 5 years116%−17.6%
Beta (5Y)1.101.18
Employees156473
StockData Score
Total score1415 (better)
Valuation score03 (better)
Growth score4 (better)2
Performance score44
Health score66
Dividend score00
Valuation
P/E128×32.7× (better)
P/S6.5×2.0× (better)
P/B5.3×4.6× (better)
EV/EBITDA107×11.2× (better)
P/FCF35.5×11.8× (better)
FCF yield2.8%8.4% (better)
Fair value$6.12$15.28
Margin of safety−236%3.7% (better)
Growth
Revenue growth (TTM)38.1% (better)2.4%
Revenue growth, 5Y average–8.1%
Net income growth (TTM)455% (better)70.9%
EPS growth (TTM)1500% (better)73.1%
EPS growth, 5Y average–−17.3%
Profitability
Gross margin87.6% (better)57.6%
Operating margin5.2%9.8% (better)
Net margin6.1%6.5% (better)
FCF margin18.3% (better)17.1%
Return on equity5.4%15.8% (better)
Return on invested capital15.5% (better)13.4%
Financial health
Debt / equity0.000.31 (better)
Net debt / EBITDA–0.39
Interest coverage–13.8×
Current ratio10.87 (better)2.68
Altman Z-score24.52 (better)5.75
Piotroski F-score78 (better)
Dividends and buybacks
Buyback yield1.2%2.1% (better)
Shareholder yield1.2%2.1% (better)
Ownership
Held by institutions50.2%79.1%
Held by insiders37.4%12.2%
Insider net buying, 12 months$150K$150K (better)
Short interest, % of float8.2%3.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.